Skip to main navigation Skip to search Skip to main content

Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk

  • Jennifer Luyapan
  • , Yohan Bosse
  • , Zhonglin Li
  • , Xiangjun Xiao
  • , Albert Rosenberger
  • , Rayjean J. Hung
  • , Stephen Lam
  • , Shanbeh Zienolddiny
  • , Geoffrey Liu
  • , Lambertus A. Kiemeney
  • , Chu Chen
  • , James McKay
  • , Mattias Johansson
  • , Mikael Johansson
  • , Adonina Tardon
  • , Guillermo Fernandez-Tardon
  • , Paul Brennan
  • , John K. Field
  • , Michael P. Davies
  • , Penella J. Woll
  • Angela Cox, Fiona Taylor, Susanne M. Arnold, Philip Lazarus, Kjell Grankvist, Maria T. Landi, David C. Christiani, Todd A. MacKenzie, Christopher I. Amos
  • Dartmouth College
  • Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval
  • Université Laval
  • Baylor College of Medicine
  • University of Göttingen
  • University of Toronto
  • Provincial Health Services Authority
  • National Institute of Occupational Health
  • University Health Network
  • Radboud University Nijmegen
  • Fred Hutchinson Cancer Research Center
  • International Agency for Research on Cancer
  • Umeå University
  • University of Oviedo
  • Ludwig Maximilian University of Munich
  • University of Liverpool
  • University of Sheffield
  • University of Kentucky
  • National Institutes of Health
  • Harvard University
  • Massachusetts General Hospital

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Pulmonary surfactant is a lipoprotein synthesized and secreted by alveolar type II cells in lung. We evaluated the associations between 200,139 single nucleotide polymorphisms (SNPs) of 40 surfactant-related genes and lung cancer risk using genotyped data from two independent lung cancer genome-wide association studies. Discovery data included 18,082 cases and 13,780 controls of European ancestry. Replication data included 1,914 cases and 3,065 controls of European descent. Using multivariate logistic regression, we found novel SNPs in surfactant-related genes CTSH [rs34577742 C > T, odds ratio (OR) = 0.90, 95% confidence interval (CI) = 0.89-0.93, P = 7.64 × 10-9] and SFTA2 (rs3095153 G > A, OR = 1.16, 95% CI = 1.10-1.21, P = 1.27 × 10-9) associated with overall lung cancer in the discovery data and validated in an independent replication data - CTSH (rs34577742 C > T, OR = 0.88, 95% CI = 0.80-0.96, P = 5.76 × 10-3) and SFTA2 (rs3095153 G > A, OR = 1.14, 95% CI = 1.01-1.28, P = 3.25 × 10-2). Among ever smokers, we found SNPs in CTSH (rs34577742 C > T, OR = 0.89, 95% CI = 0.85-0.92, P = 1.94 × 10-7) and SFTA2 (rs3095152 G > A, OR = 1.20, 95% CI = 1.14-1.27, P = 4.25 × 10-11) associated with overall lung cancer in the discovery data and validated in the replication data - CTSH (rs34577742 C > T, OR = 0.88, 95% CI = 0.79-0.97, P = 1.64 × 10-2) and SFTA2 (rs3095152 G > A, OR = 1.15, 95% CI = 1.01-1.30, P = 3.81 × 10-2). Subsequent transcriptome-wide association study using expression weights from a lung expression quantitative trait loci study revealed genes most strongly associated with lung cancer are CTSH (PTWAS = 2.44 × 10-4) and SFTA2 (PTWAS = 2.32 × 10-6).

Original languageEnglish
Pages (from-to)2842-2855
Number of pages14
JournalHuman Molecular Genetics
Volume32
Issue number18
DOIs
StatePublished - Sep 15 2023

Fingerprint

Dive into the research topics of 'Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk'. Together they form a unique fingerprint.

Cite this